THE EFFECT OF SU JOK THERAPY ON DYSPNEA AND INSOMNIA IN PATIENTS WITH ASTHMA: A RANDOMIZED CONTROLLED TRIAL
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 26
- 试验地点
- 1
- 主要终点
- Dyspnea severity
研究概览
简要总结
Asthma is a long-term lung disease that can make breathing difficult and can also affect sleep. Even with regular medical treatment, many people with asthma continue to experience shortness of breath and insomnia. This study will examine whether Su Jok therapy, a complementary therapy that applies gentle stimulation to specific points on the hands and feet, can help reduce shortness of breath and improve sleep in people with asthma. Adults with asthma who agree to participate will be randomly assigned to one of two groups. One group will receive Su Jok therapy in addition to their usual care, while the other group will receive usual care only. Researchers will compare changes in breathing difficulty and sleep quality between the two groups.
The results of this study may help determine whether Su Jok therapy can be used as a safe and supportive treatment alongside standard asthma care.
详细描述
Asthma is a chronic inflammatory disease of the airways that is characterized by recurrent episodes of dyspnea, wheezing, cough, and chest tightness. Despite advances in pharmacological treatment, many people with asthma continue to experience persistent symptoms, particularly dyspnea and sleep disturbances, which may negatively affect daily functioning and quality of life.
Complementary therapies are increasingly being investigated as supportive approaches to symptom management. Su Jok therapy is a complementary therapy based on the stimulation of specific points on the hands and feet that correspond to different parts of the body. It has been suggested that this approach may help relieve symptoms and improve overall well-being.
This randomized controlled trial aims to evaluate the effect of Su Jok therapy on dyspnea and insomnia in adults with asthma. Participants will be randomly assigned to either an intervention group receiving Su Jok therapy in addition to routine care or a control group receiving routine care alone. Dyspnea and insomnia will be assessed before and after the intervention using validated measurement instruments. The findings of this study are expected to provide evidence regarding the potential role of Su Jok therapy as a complementary, non-pharmacological intervention for symptom management in individuals with asthma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults aged 18 years or older.
- •Diagnosed with asthma by a physician.
- •A baseline Visual Analog Scale (VAS) score of 3 or higher for both dyspnea and insomnia.
- •Receiving routine asthma treatment.
- •Able to communicate in Turkish.
- •Able to understand the study procedures and provide written informed consent.
- •Willing to participate in the study.
排除标准
- •Presence of severe cognitive or psychiatric disorders that could interfere with participation.
- •Presence of skin lesions, infection, or injury on the hands that would prevent Su Jok therapy.
- •Participation in another clinical trial during the study period.
- •Withdrawal of consent at any stage of the study.
研究组 & 干预措施
Su Jok Therapy Group
Participants in this group will receive routine asthma care plus five consecutive daily sessions of Su Jok therapy. Dyspnea and insomnia symptoms will be assessed daily using the Visual Analog Scale (VAS). Questionnaire data will be collected before the intervention (baseline) and after completion of the intervention (post-test).
干预措施: su jok therapy (Other)
Control Group
Participants in this group will receive routine asthma care only. Dyspnea and insomnia symptoms will be assessed daily for five consecutive days using the Visual Analog Scale (VAS). Questionnaire data will be collected at baseline and after the study period (post-test).
结局指标
主要结局
Dyspnea severity
时间窗: Baseline and daily for 5 consecutive days, with post-intervention assessment on Day 5.
Dyspnea severity will be assessed using the Visual Analog Scale (VAS). Higher scores indicate greater dyspnea severity.
次要结局
- Insomnia severity(Baseline and post-intervention (Day 5).)
研究者
Demet GÜNEŞ
Assistant Professor
Erzincan Binali Yildirim Universitesi